Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
07/2007
07/18/2007EP1807432A1 Halogen substituted benzodiazepine derivatives
07/18/2007EP1807429A2 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
07/18/2007EP1807428A2 Process for preparing quinoline compounds and products obtained therefrom
07/18/2007EP1807427A2 Substituted indolizines and derivatives as cns agents
07/18/2007EP1807404A1 Novel use
07/18/2007EP1807392A1 6-amino(aza)indane compounds suitable for treating disorders that respond to modulation of the dopamine d3 recptor
07/18/2007EP1807387A2 Substituted tetracycline compounds
07/18/2007EP1807157A2 Use of apoptosis inhibiting compounds in degenerative neurological disorders
07/18/2007EP1807156A1 New pharmaceutical formulations useful in the treatment of insomnia
07/18/2007EP1807088A1 Formulations of [1,4]diazepino[6,7,1-ij]quinoline derivatives
07/18/2007EP1807071A2 Antipyretic compositions and methods
07/18/2007EP1725239B1 4-(sulfanyl-pyrimidin-4-ylmethyl)-morpholine derivatives and related compounds as gaba receptor ligands for the treatment of anxiety, depression and epilepsy
07/18/2007EP1663981B1 Piperazinyl-quinoline derivatives useful for the treatment of cns disorders
07/18/2007EP1603912B1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators
07/18/2007EP1558598B1 Triazole compounds for the treatment of dysmenorrhoea
07/18/2007EP1525204B1 Phenylalanine enamide derivatives
07/18/2007EP1458711B1 Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer s disease and conditions associated with glycogen synthase kinase-3
07/18/2007EP1373224B1 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
07/18/2007EP1313707B1 Quinoline derivatives as anti-inflammation agents
07/18/2007EP1178780B1 Multiparticulate controlled release selective serotonin reuptake inhibitor formulations
07/18/2007EP1150678B1 Use of 3-hydroxy-3-methylglutaryl coenzym a reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy
07/18/2007EP1143938B1 Transdermal therapeutic system with self-adhesive matrix, containing organic acid addition salts of morphine- or morphinan-type alkaloids
07/18/2007EP1054885B1 Benzisoxazole derivatives having d4-antagonistic activity
07/18/2007CN1326858C Novel tricyclic spiropiperidines or spiropyrrolidines
07/18/2007CN1326857C Novel 1,4-diazabicycloalkane derivatives, their preparation and use
07/18/2007CN1326855C Ring fused pyrazole derivatives
07/18/2007CN1326854C Substituted derivatives of aminofuran-2-Y1-acetic acid and aminothien-2-Y1-acetic acid and use thereof for treating migraines and pain
07/18/2007CN1326848C Aminopyrazole derivatives
07/18/2007CN1326841C Arylalkane-sulfonamides having endothelin-antagonist activity
07/18/2007CN1326838C Benzo[d]azepine derivatives for the treatment of neurological disorders
07/18/2007CN1326563C Use of the long pentraxin PTX3 for the preparation of medicament for the prevention and cure of autoimmune pathologies
07/18/2007CN1326560C Use of POLY-GLU,TYR treated therewith for neuroprotective therapy
07/18/2007CN1326549C Chinese medicine for treating blood vessel nature feeble-mindedness
07/18/2007CN1326538C Pain relieving cancer treating decoction and its preparation method
07/18/2007CN1326529C Relaxation of Climacteric syndrome by using antisenility action of glossy ganoderma
07/18/2007CN1326522C Methods of using and compositions comprising immunomodulatory compounds for treatment, modification and management of pain
07/18/2007CN1326518C Peripateticism soft capsule and its preparation technology
07/18/2007CN1326467C Ketoprofen-supplemented animal feed and use thereof in the simultaneous treatment of a group of animals for processes
07/18/2007CN101001862A Tricyclic compounds and their use as MGLUR1 antagonists
07/18/2007CN101001861A Substituted thienopyrrole carboxylic acid amides, pyrrolothiazole carboxylic acid amides, and related analogs as inhibitors of casein kinase i epsilon
07/18/2007CN101001857A 2-(pyridin-2-ylamino)-pyrido [2,3-d]pyrimidin-7-ones
07/18/2007CN101001856A Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof
07/18/2007CN101001849A Sulfamate and sulfamide derivatives for the treatment of epilepsy and related disorders
07/18/2007CN101001846A Novel alkynyl derivatives as modulators of metabotropic glutamate receptors
07/18/2007CN101001670A Compositions for sleeping disorders
07/18/2007CN101001646A Stabilized synthetic immunogen delivery system
07/18/2007CN101001630A Combination of selective noradrenalin reabsorption inhibitor and PDEV inhibitor
07/18/2007CN101001627A Pyrazolone compounds useful for treatment of cerebrovascular disorders associated with ischemic stroke
07/18/2007CN101001622A Capsule stable against mastication
07/18/2007CN100999546A Polypeptide compound with aza-containing heterocyclic modified and its application
07/18/2007CN100999510A Preparation of noncrystal form ede plene oxalate and its coprecipitate
07/18/2007CN100999496A Compound of polyphenols with aza-containing heterocyclic modified and use thereof
07/18/2007CN100999495A Compound of styryl with axa-containing heterocyclic modified and use thereof
07/18/2007CN100998861A Cerebroprotein hydrolysate sodium chloride injection
07/18/2007CN100998855A Oral Chinese medicine for treating severe headache type hypertension
07/18/2007CN100998848A Decoction for treating cold of insufficiency type ischialyia and its preparation method
07/18/2007CN100998846A Membrane production technology of spirit quieting brain supplementing liquid and its product
07/18/2007CN100998838A Chinese medicine for relaxing muscles and tendons to promote blood circulation preparation method thereof
07/18/2007CN100998772A Oral traditional Chinese medicine for treating trigeminal neuralgia of blood stasis type
07/18/2007CN100998771A Oral traditional Chinese medicine for treating trigeminal neuralgia of abundant expectoration type
07/18/2007CN100998770A Hypertensor plaster with tranquilizing function
07/18/2007CN100998757A Medicine for relieving pain and strengthening teeth
07/18/2007CN100998755A Oral traditional Chinese medicine for treating insomnic hypertension
07/18/2007CN100998748A Oral traditional Chinese medicine for treating serious hyposomnia of deficiency of gallbladder-qi
07/18/2007CN100998747A Oral traditional Chinese medicine for treating serious hyposomnia of breakdown of the normal physiological coordination between the heart and the kidney type
07/18/2007CN100998744A Chinese patent drug for treating infantile hyperkinetic syndrome
07/18/2007CN100998741A Traditional Chinese medicine composition for treating pains of articulus and soft tissue, and plaster thereof and its preparing method
07/18/2007CN100998733A Oral traditional Chinese medicine for treating trigeminal neuralgia of prolonged illness entering subsidiary channels type
07/18/2007CN100998711A Oral traditional Chinese medicine for treating serous anhypnia of food staying and indigestion type
07/18/2007CN100998710A Traditional Chinese medicine composition for treating depression and its preparing method
07/18/2007CN100998707A Medical herbs of decoction for treating sciatica and its preparing method
07/18/2007CN100998705A Oral traditional Chinese medicine for treating damp-heat type trifacial neuralgia
07/18/2007CN100998698A Dietotherapy drug giving-up beverage with nourishing function
07/18/2007CN100998682A Oral traditional Chinese medicine for treating serious hyposomnia of qi-blood disharmony type
07/18/2007CN100998666A Oral traditional Chinese medicine for treating trifacial neuralgia of cold-condensing and blood-stasis type
07/18/2007CN100998664A Oral traditional Chinese medicine for treating critical anhypnia of insulfficiency of the spleen-qi type
07/18/2007CN100998663A Oral traditional Chinese medicine for treating breakdown of the normal physiological coordination between heart and kidney type anhypnia
07/18/2007CN100998630A Plaster for treating hyperosteogeny, neuro-pain and various kinds of inflammation
07/18/2007CN100998606A Application of senso for preparing traditional Chinese medicine plaster to treat facial neuroparalysis
07/18/2007CN100998602A Application of chondroition sulfate for preparing medicine to relieve chronic pain
07/18/2007CN100998598A Application of glycosamine for preparing medicine to relieve chronic pain
07/18/2007CN100998585A Injection containing meclofenoxate hydrochloride and its preparing method
07/18/2007CN100998579A Hydrophillia Babu agent for treating depression
07/18/2007CN100998409A Raw material for making health-care food with functions of tonifying, refreshing and lowering user's weight and its product
07/18/2007CN100998313A Production method of ginseng culture root extraction with high content of ginsenoside and its use
07/17/2007US7244846 Substituted benzofuran-2-carboxamides derivatives
07/17/2007US7244843 Modulators of serotonin receptors
07/17/2007US7244818 Interferon alpha responsive protein
07/17/2007US7244761 Nerve regeneration promoters containing semaphorin inhibitor as the active ingredient
07/17/2007US7244758 N-type calcium channel blockers
07/17/2007US7244755 Hydroxypropylamines
07/17/2007US7244754 For therapy of Parkinson, Huntington's chorea, cerebral circulatory disorders, ischemia, cerebral ischemia, apoplexy, cerebral apoplexy, senile dementia, and Alzheimer's disease
07/17/2007US7244753 Cyclooxygenase-2 selective inhibitors, compositions and methods of use
07/17/2007US7244746 Imidazolyl derivatives as corticotropin releasing factor inhibitors
07/17/2007US7244745 Heterocyclic compounds, methods for the preparation thereof, and uses thereof
07/17/2007US7244744 Useful in treatment of diseases through the inhibition of sodium ion flux through voltage-dependent sodium channels; treatment of central or peripheral nervous system disorders, particularly pain and chronic pain by blocking sodium channels
07/17/2007US7244730 Thrombin receptor antagonists; safety, specificity, oral efficacy
07/17/2007US7244726 Heterocyclic compounds possessing affinity at 5HT1 -type receptors and use thereof in therapy
07/17/2007US7244722 5-HT2A receptor related disorders; such as 1-(2-(2-fluoro-4-nitrophenoxy)ethyl)-3-(1piperazinyl)-2(1H)-pyrazinone
07/17/2007US7244718 Derivatives of water insoluble drugs which exhibit good activity and water solubility; producing an anesthetic effect in a dog